101 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
102 |
AbbVie Inc. v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-01236 |
D.Del. |
|
|
|
|
103 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
104 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
105 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
106 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
107 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
108 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
109 |
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al |
1:14-cv-04508 |
D.N.J. |
|
|
|
|
110 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
111 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
112 |
AstraZeneca AB v. Mylan Pharmaceuticals Inc. |
1:14-cv-00094 |
N.D.W.Va. |
|
|
|
|
113 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
114 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
115 |
WARNER CHILCOTT COMPANY, LLC v. MYLAN INC. et al |
3:13-cv-06560 |
D.N.J. |
|
|
|
|
116 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
117 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
118 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
119 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
120 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
121 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
122 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
123 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
124 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
125 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
126 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
127 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
128 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
129 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
130 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
131 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
132 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
133 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
134 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
135 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
136 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
137 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
138 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
139 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
140 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
141 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
142 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
143 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
144 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
145 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
146 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
147 |
OREXO AB v. MYLAN PHARMACEUTICALS INC. et al |
3:11-cv-03788 |
D.N.J. |
|
|
|
|
148 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
149 |
DTECH Communications, LLC v. OSC Engineering, Inc. et al |
3:11-cv-01425 |
S.D.Cal. |
|
|
|
|
150 |
Bayer Schering Pharma AG et al v. Mylan Pharmaceuticals Inc. et al |
2:11-cv-00604 |
D.Nev. |
|
|
|
|